Abiogen Pharma
Status
ACTIVE
Global HQ
Pisa, Italy
Countries of investment
- Italy
- Germany
- Switzerland
- United Kingdom
- Ireland
- Spain
- Greece
- Portugal
- Mexico
- China
- Taiwan
- Saudi Arabia
- Iraq
- Israel
- United Arab Emirates
- Canada
Investment stages
- Series B
- Series C
- Growth
Industries
- Pharmaceuticals
- Biotechnology
- Life Sciences
About
Abiogen Pharma drives pharmaceutical innovation as a leading Italian player specializing in endocrinology, pain management, rare diseases, bone health, and orphan conditions, expanding globally through strategic acquisitions, robust R&D pipelines, and partnerships across Europe, Asia, and the Americas for patient-centric advancement.
Abiogen Pharma drives pharmaceutical innovation as a leading Italian player specializing in endocrinology, pain management, rare diseases, bone health, and orphan conditions, expanding globally through strategic acquisitions, robust R&D pipelines, and partnerships across Europe, Asia, and the Americas for patient-centric advancement.
Investment Thesis
Abiogen Pharma advances pharmaceutical innovation in endocrinology, pain management, rare diseases, and musculoskeletal health through R&D excellence, global partnerships, and patient-focused product development.
Manager's Experience
Led by pharmaceutical and biotech executives with deep experience in drug development, clinical research, and commercialization within regulated markets.
Team
Massimo Di Martino - Chairman and President
Paolo Zambonardi - Chief Executive Officer
Portfolio
EffRx
Altamedics